This inventor holds 18 USPTO granted patents and 25 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Lipocine Inc., Spriaso LLC, Other. Active years: 2015-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2022
Areas of Expertise:
Title: **Srinivansan Venkateshwaran: Innovator in Pharmaceutical Compositions**
Introduction
Srinivansan Venkateshwaran, an accomplished inventor based in Salt Lake City, UT, has made significant contributions to the field of pharmaceuticals, securing a remarkable total of 18 patents throughout his career. His innovations primarily focus on formulations that enhance bioavailability and therapeutic effectiveness in various medicinal applications.
Latest Patents
Among his latest patents is the invention titled "17-hydroxyprogesterone ester-containing oral compositions and related methods." This innovative work details bioavailable oral dosage forms that include esters of 17-hydroxyprogesterone. These compositions are designed for pregnancy support and include a therapeutically effective amount of the ester along with a pharmaceutically acceptable carrier. Furthermore, the oral dosage forms are formulated to ensure optimal release of the active ingredient when tested under specific conditions using a USP Type-II dissolution apparatus.
Another notable patent is for "High-strength testosterone undecanoate compositions." This patent involves pharmaceutical compositions and oral dosage capsules that contain testosterone undecanoate. The innovative capsule design incorporates a solubilizer and is formulated to provide a precise serum testosterone concentration when administered in recommended doses. This invention aims to enhance male health by maintaining optimal testosterone levels.
Career Highlights
Throughout his career, Srinivansan Venkateshwaran has actively contributed to the pharmaceutical industry, particularly during his tenure at Lipocine Inc. His focus on developing innovative oral dosage forms has garnered him recognition among peers and industry leaders alike. His extensive portfolio showcases his commitment to advancing therapeutic options for patients in need.
Collaborations
Srinivansan has worked closely with esteemed colleagues, including Chandrashekar Giliyar and Mahesh V Patel. Their collaboration has fostered an environment of innovation, allowing for the exploration of new ideas and technologies within the realm of pharmaceutical development.
Conclusion
Srinivansan Venkateshwaran's contributions to the field of pharmaceuticals are evident through his 18 patents and impactful innovations. His work on oral dosage forms and hormone compositions reflects a dedication to improving patient outcomes and advancing pharmaceutical sciences. With a promising career ahead, he continues to inspire future inventors in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile